Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

This Special Issue is a collection of selected papers from the 3rd European Congress on Imaging Infection and Inflammation (www.nuclearmedicinediscovery.org/events.asp) and results of consensus sessions by major experts in the field including Nuclear Medicine physicians, Radiologists, Clinicians and microbiologists. The Journal of Clinical Medicine (JCM) provides an opportunity to publish data that were presented and discussed at the meeting in Rome in December 2019. One of the extremely important missions of this meeting was to present the recently published guidelines on diagnostic imaging of infections, and find a consensus agreement on some still controversial issues. With this in mind, the aim of the present Special Issue is to publish selected papers on: • Overviews on published guidelines • Review on recent development of diagnostic imaging of infections • Consensus document on the use of FDG and WBC in infections • Consensus document on the requirement for new radiopharmaceuticals for imaging bacteria

Medicine --- infection --- vascular graft --- multimodality imaging --- WBC scintigraphy --- FDG-PET/CT --- angio-CT --- personalized medicine --- spondylodiscitis --- spine infection --- MRI --- 18F-FDG PET/CT --- diabetic foot --- diagnosis --- FDG PET/CT --- polymeric nanoparticles --- PLGA --- optical imaging --- tumor targeting --- imaging --- [18F]FDG PET/CT --- fever of unknown origin --- FUO --- PET/CT --- 18F-FDG-PET/CT --- Infective endocarditis --- echocardiography --- computed tomography --- magnetic resonance imaging --- nuclear imaging --- positron emission tomography --- endocarditis team --- cardiac implantable electronic device --- bacteria --- radiopharmaceutical --- molecular imaging --- nuclear medicine --- prosthetic joint infection --- SPECT/CT --- radiology

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

This Special Issue is a collection of selected papers from the 3rd European Congress on Imaging Infection and Inflammation (www.nuclearmedicinediscovery.org/events.asp) and results of consensus sessions by major experts in the field including Nuclear Medicine physicians, Radiologists, Clinicians and microbiologists. The Journal of Clinical Medicine (JCM) provides an opportunity to publish data that were presented and discussed at the meeting in Rome in December 2019. One of the extremely important missions of this meeting was to present the recently published guidelines on diagnostic imaging of infections, and find a consensus agreement on some still controversial issues. With this in mind, the aim of the present Special Issue is to publish selected papers on: • Overviews on published guidelines • Review on recent development of diagnostic imaging of infections • Consensus document on the use of FDG and WBC in infections • Consensus document on the requirement for new radiopharmaceuticals for imaging bacteria

Medicine --- infection --- vascular graft --- multimodality imaging --- WBC scintigraphy --- FDG-PET/CT --- angio-CT --- personalized medicine --- spondylodiscitis --- spine infection --- MRI --- 18F-FDG PET/CT --- diabetic foot --- diagnosis --- FDG PET/CT --- polymeric nanoparticles --- PLGA --- optical imaging --- tumor targeting --- imaging --- [18F]FDG PET/CT --- fever of unknown origin --- FUO --- PET/CT --- 18F-FDG-PET/CT --- Infective endocarditis --- echocardiography --- computed tomography --- magnetic resonance imaging --- nuclear imaging --- positron emission tomography --- endocarditis team --- cardiac implantable electronic device --- bacteria --- radiopharmaceutical --- molecular imaging --- nuclear medicine --- prosthetic joint infection --- SPECT/CT --- radiology

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

The issue of Cancers Journal entitled “Role of Medical Imaging in Cancers” presents a detailed summary of evidences about molecular imaging, including the role of computed tomography (CT), magnetic resonance imaging (MRI), single photon emission tomography (SPET) and positron emission tomography (PET) or PET/CT or PET/MR imaging in many type of tumors (i.e. sarcoma, prostate, breast and others), motivating the role of these imaging modalities in different setting of disease and showing the recent developments, in terms of radiopharmaceuticals, software and artificial intelligence in this field. The collection of articles is very useful for many specialists, because it has been conceived for a multidisciplinary point of view, in order to drive to a personalized medicine.

Medicine. --- positron emission tomography --- head and neck neoplasms --- neovascularization --- pathologic --- PET/CT --- urothelial carcinoma --- bladder cancer --- upper tract urothelial carcinoma --- survival --- PET --- PSMA --- prostate --- DCFPyL --- DCFBC --- PSMA-1007 --- ovarian cancer --- relapse --- SUVmax --- targeted therapy --- prognosis --- soft tissue sarcoma (STS) --- pazopanib --- dynamic 18F-FDG PET/CT --- SUV --- two-tissue compartment model --- magnetic resonance imaging --- machine learning --- diffusion --- perfusion --- texture analysis --- squamous cell carcinoma of the head and neck --- diffusion-weighted imaging --- malignant pleural mesothelioma --- pleural dissemination --- empyema --- pleural effusion --- mCRPC --- SPECT/CT --- Computer-assisted diagnosis --- XOFIGO --- Therapy response assessment --- circulating miRNAs --- breast cancer --- imaging parameters --- PET/MRI --- biomarkers --- triple negative breast cancer --- VCAM-1 --- SPECT imaging --- sdAbs --- Hounsfield unit --- computed tomography --- adipose tissue --- precision oncology --- FDG-PET/CT --- PERCIST --- metastatic breast cancer --- prostate cancer --- 18F-FACBC --- recurrence --- meta-analysis --- review --- meningioma --- somatostatin receptor --- neuroimaging --- radionuclide therapy --- breast --- imaging --- marker --- radiomics --- Yin Yang 1 --- PDAC --- Mesothelin --- noninvasive imaging --- receptor status --- molecular imaging --- nuclear medicine --- guidelines --- overutilization --- epistemology --- consensus --- mantle cell lymphoma --- 18F-FDG PET/CT --- Deauville criteria --- Radium-223 --- FDG --- castrate resistant prostate cancer --- programmed cell death 1 receptor --- diagnostic imaging --- CTLA-4 Antigen --- Immunotherapy --- Adoptive --- radioactive tracers --- radionuclide imaging --- CD8-Positive T-Lymphocytes --- PI-RADS --- diffusion kurtosis imaging --- dynamic contrast-enhanced magnetic resonance imaging --- 68Gallium-PSMA PET/CT --- prostate-specific-antigen --- PSA kinetics thresholds --- biochemical recurrence --- optimal cutoff level --- non-small-cell lung cancer --- circulating tumor cells --- immunotherapy --- response to treatment --- head and neck cancer --- HPV --- EBV --- p16 --- Molecular imaging --- miRNA expression --- radiogenomics --- radiomic --- diagnosis --- biomarker --- glioblastoma --- radiation therapy --- MRI --- diffusion tensor imaging --- Hodgkin lymphoma --- diffuse large B-cell lymphoma --- staging --- response assessment --- locally advanced cervical cancer --- concurrent chemoradiotherapy --- treatment response --- follow up --- cystic tumor --- International Consensus Guidelines --- intraductal papillary mucinous neoplasms --- pancreatic neoplasms --- PD-1 --- PD-L1 --- response to therapy --- NSCLC --- positron-emission tomography --- single-photon emission computed tomography --- immune checkpoint inhibitors --- gold nanoparticle --- heat shock protein 70 --- spectral-CT --- n/a

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

undefined

Medicine. --- positron emission tomography --- head and neck neoplasms --- neovascularization --- pathologic --- PET/CT --- urothelial carcinoma --- bladder cancer --- upper tract urothelial carcinoma --- survival --- PET --- PSMA --- prostate --- DCFPyL --- DCFBC --- PSMA-1007 --- ovarian cancer --- relapse --- SUVmax --- targeted therapy --- prognosis --- soft tissue sarcoma (STS) --- pazopanib --- dynamic 18F-FDG PET/CT --- SUV --- two-tissue compartment model --- magnetic resonance imaging --- machine learning --- diffusion --- perfusion --- texture analysis --- squamous cell carcinoma of the head and neck --- diffusion-weighted imaging --- malignant pleural mesothelioma --- pleural dissemination --- empyema --- pleural effusion --- mCRPC --- SPECT/CT --- Computer-assisted diagnosis --- XOFIGO --- Therapy response assessment --- circulating miRNAs --- breast cancer --- imaging parameters --- PET/MRI --- biomarkers --- triple negative breast cancer --- VCAM-1 --- SPECT imaging --- sdAbs --- Hounsfield unit --- computed tomography --- adipose tissue --- precision oncology --- FDG-PET/CT --- PERCIST --- metastatic breast cancer --- prostate cancer --- 18F-FACBC --- recurrence --- meta-analysis --- review --- meningioma --- somatostatin receptor --- neuroimaging --- radionuclide therapy --- breast --- imaging --- marker --- radiomics --- Yin Yang 1 --- PDAC --- Mesothelin --- noninvasive imaging --- receptor status --- molecular imaging --- nuclear medicine --- guidelines --- overutilization --- epistemology --- consensus --- mantle cell lymphoma --- 18F-FDG PET/CT --- Deauville criteria --- Radium-223 --- FDG --- castrate resistant prostate cancer --- programmed cell death 1 receptor --- diagnostic imaging --- CTLA-4 Antigen --- Immunotherapy --- Adoptive --- radioactive tracers --- radionuclide imaging --- CD8-Positive T-Lymphocytes --- PI-RADS --- diffusion kurtosis imaging --- dynamic contrast-enhanced magnetic resonance imaging --- 68Gallium-PSMA PET/CT --- prostate-specific-antigen --- PSA kinetics thresholds --- biochemical recurrence --- optimal cutoff level --- non-small-cell lung cancer --- circulating tumor cells --- immunotherapy --- response to treatment --- head and neck cancer --- HPV --- EBV --- p16 --- Molecular imaging --- miRNA expression --- radiogenomics --- radiomic --- diagnosis --- biomarker --- glioblastoma --- radiation therapy --- MRI --- diffusion tensor imaging --- Hodgkin lymphoma --- diffuse large B-cell lymphoma --- staging --- response assessment --- locally advanced cervical cancer --- concurrent chemoradiotherapy --- treatment response --- follow up --- cystic tumor --- International Consensus Guidelines --- intraductal papillary mucinous neoplasms --- pancreatic neoplasms --- PD-1 --- PD-L1 --- response to therapy --- NSCLC --- positron-emission tomography --- single-photon emission computed tomography --- immune checkpoint inhibitors --- gold nanoparticle --- heat shock protein 70 --- spectral-CT

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

This reprint is related to the latest research in the field of thyroid surgery, including molecular and imaging diagnosis, surgical treatment, and the treatment of recurrent disease and advanced thyroid carcinoma.

Medicine --- Oncology --- thyroid carcinoma --- prophylactic central lymph node dissection --- lymph node metastases --- RET --- medullary thyroid carcinoma --- clinical management --- variants of uncertain significance --- differentiated thyroid cancer --- papillary thyroid cancer --- minimal extrathyroidal extension --- radioactive iodine therapy --- prognosis --- TNM --- histology --- multifocality --- lymph node metastasis --- vascular invasion --- autoimmune thyroid diseases --- radioiodine refractory --- Lenvatinib --- 18F-FDG-PET/CT --- cost-benefit analysis --- economics --- medical --- thyroid neoplasms --- radiomics --- ultrasound --- magnetic resonance imaging --- computer tomography --- prediction --- classification --- angiogenic microenvironment --- prognostic factors --- antiangiogenic therapy --- therapeutic target --- tumor microenvironment --- tumor behavior --- proliferation pathways --- cell cycle control pathways --- angiogenesis process --- thyroid cancer --- Gal-3 expression --- NIFTP --- EFVPTC --- lymphocytic thyroiditis (LT) --- immunohistochemical (IHC) analysis --- molecular imaging --- theranostics --- companion diagnostics --- immunoPET --- anaplastic thyroid cancer --- poorly thyroid cancer --- genetic landscape --- genetically guided therapy --- fluorodeoxyglucose F18 (18F-FDG) --- positron emission tomography (PET) --- magnetic resonance imaging (MRI) --- recurrence --- neoplasm metastasis --- thyroid surgery --- hypoparathyroidism --- fluorescence-guided surgery --- near-infrared autofluorescence --- PRKAR1A --- PKA --- Carney complex --- cAMP --- bone metastasis --- metastasectomy --- stereotactic radiosurgery --- ultrasound imaging --- thyroid nodule --- fine-needle aspiration --- papillary thyroid carcinoma --- lobectomy --- operative extent --- CONUT score --- tyrosine kinase inhibitors